The Industry Standard: Intelligence for the Information Economy

  September 5, 2001
  NEWS & ANALYSIS
   Headlines
   Money & Markets
   Tech & Telecom
   Media & Marketing
   Metrics & Stats
   Policy & Politics
  SEARCH
   
  advanced search
  SERVICES
   Company Index
   Newsletters
   Wireless
  PRINT EDITION
   Read the Magazine

Home > Company Index > Drugs > Drug Manufacturers - Other > Cell Pathways, Inc.

Cell Pathways, Inc.
Nasdaq: CLPA
Change
symbol:
     
 PROFILE
Cell Pathways wants cancer cells to commit suicide. The development-stage company is working on anti-cancer drugs that induce selective apoptosis (programmed cell death) in precancerous and cancerous cells. Lead drug candidate Aptosyn (formerly named Prevatec) is under FDA review as a treatment for various types of cancerous and precancerous lesions. It is intended for use in treating throat, colon, cervix, prostate, lung, and breast cancers and precancerous conditions. Cell Pathways plans to develop more drugs using apoptosis technology; it has collaborative agreements with the National Cancer Institute and the University of Arizona.

 COMPETITION
ILEX Oncology, Inc. (ILXO)
OSI Pharmaceuticals, Inc. (OSIP)
Vertex Pharmaceuticals Incorporated (VRTX)

 STOCK ANALYSIS
 View by:
 Day 
 Day 
 Month 
 Month 
 Year 
 Year 
FURTHER ANALYSIS
• Advanced Charting
• Deals

 FINANCIAL OVERVIEW
Fiscal Year-End: December
2000 Sales (mil.): 0.30
1-Yr. Sales Growth: 200.0%
Employees: 60
Revenue per employee: $5,000.00

 KEY PEOPLE
• Robert J. Towarnicki
    CEO
• Brian J. Hayden
    CFO

 CONTACT INFO
702 Electronic Dr.
Horsham, PA 19044
US
Phone: 215-706-3800
Fax: 215-706-3801
Online: Web Site

Company Data   News, quotes & more       

Hoovers Online   Hoover's Company Capsule
Copyright © 2001, Hoover's Inc. Austin, Texas.
For changes and updates, contact Hoover's directly.


ADVERTISEMENT
FEATURED LINKS
Home |  Customer Service |  About Us
Australia |  Brazil |  China |  Korea |  Norway |  Poland |  Sweden |  Taiwan

Copyright ©2001 Standard Media International. Privacy Policy
Stock data provided by Stockpoint and its data suppliers. Copyright © 1995-2001